{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T06:31:25Z","timestamp":1790231485739,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"S6","license":[{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1007\/s00415-008-6007-9","type":"journal-article","created":{"date-parts":[[2009,3,19]],"date-time":"2009-03-19T10:41:07Z","timestamp":1237459267000},"page":"36-42","source":"Crossref","is-referenced-by-count":21,"title":["Corticosteroids and plasma exchange in multiple sclerosis"],"prefix":"10.1007","volume":"255","author":[{"given":"Hayretin","family":"Tumani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"7007_CR1","doi-asserted-by":"crossref","unstructured":"Anonymous (1991) The Canadian cooperative trial of cyclophosphamide and plasma exchange in progressive multiple sclerosis. The Canadian Cooperative Multiple Sclerosis Study Group. Lancet 337:441\u2013446","DOI":"10.1016\/0140-6736(91)93389-Q"},{"key":"7007_CR2","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1136\/jnnp.56.11.1219","volume":"56","author":"Alam","year":"1993","unstructured":"Alam SM, Kyriakides T, Lawden M, Newman PK (1993) Methylprednisolone in multiple sclerosis: a comparison of oral with intravenous therapy at equivalent high dose. J Neurol Neurosurg Psychiatry 56:1219\u20131220","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"7007_CR3","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/S0140-6736(96)06453-7","volume":"349","author":"Barnes","year":"1997","unstructured":"Barnes D, Hughes RA, Morris RW, Wade-Jones O, Brown P, Britton T, Francis DA, Perkin GD, Rudge P, Swash M, Katifi H, Farmer S, Frankel J (1997) Randomised trial of oral and intravenous methylprednisolone in acute relapses of multiple sclerosis. Lancet 349:902\u2013906","journal-title":"Lancet"},{"key":"7007_CR4","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1001\/archopht.1995.01100020014004","volume":"113","author":"Beck","year":"1995","unstructured":"Beck RW (1995) The optic neuritis treatment trial: three-year follow-up results. Arch Ophthalmol 113:136\u2013137","journal-title":"Arch Ophthalmol"},{"key":"7007_CR5","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1056\/NEJM199202273260901","volume":"326","author":"Beck","year":"1992","unstructured":"Beck RW, Cleary PA, Anderson MM Jr, Keltner JL, Shults WT, Kaufman DI, Buckley EG, Corbett JJ, Kupersmith MJ, Miller NR, et al. (1992) A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group. N Engl J Med 326:581\u2013588","journal-title":"N Engl J Med"},{"key":"7007_CR6","doi-asserted-by":"crossref","unstructured":"Ciccone A, Beretta S, Brusaferri F, Galea I, Protti A, Spreafico C (2008) Corticosteroids for the long-term treatment in multiple sclerosis. Cochrane Database Syst Rev:CD006264","DOI":"10.1002\/14651858.CD006264.pub2"},{"key":"7007_CR7","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1177\/1352458507083189","volume":"14","author":"Cohen","year":"2008","unstructured":"Cohen JA, Calabresi PA, Chakraborty S, Edwards KR, Eickenhorst T, Felton WL 3rd, Fisher E, Fox RJ, Goodman AD, Hara-Cleaver C, Hutton GJ, Imrey PB, Ivancic DM, Mandell BF, Perryman JE, Scott TF, Skaramagas TT, Zhang H (2008) Avonex Combination Trial in relapsing \u2013 remitting MS: rationale, design and baseline data. Mult Scler 14:370\u2013382","journal-title":"Mult Scler"},{"key":"7007_CR8","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1136\/jnnp.50.5.517","volume":"50","author":"Compston","year":"1987","unstructured":"Compston DA, Milligan NM, Hughes PJ, Gibbs J, McBroom V, Morgan BP, Campbell AK (1987) A double-blind controlled trial of high dose methylprednisolone in patients with multiple sclerosis: 2. Laboratory results. J Neurol Neurosurg Psychiatry 50:517\u2013522","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"7007_CR9","unstructured":"Filippini G, Brusaferri F, Sibley WA, Citterio A, Ciucci G, Midgard R, Candelise L (2000) Corticosteroids or ACTH for acute exacerbations in multiple sclerosis. Cochrane Database Syst Rev:CD001331"},{"key":"7007_CR10","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.nurt.2007.07.008","volume":"4","author":"Frohman","year":"2007","unstructured":"Frohman EM, Shah A, Eggenberger E, Metz L, Zivadinov R, Stuve O (2007) Corticosteroids for multiple sclerosis: I. Application for treating exacerbations. Neurotherapeutics 4:618\u2013626","journal-title":"Neurotherapeutics"},{"key":"7007_CR11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-5728(01)00330-7","volume":"117","author":"Gold","year":"2001","unstructured":"Gold R, Buttgereit F, Toyka KV (2001) Mechanism of action of glucocorticosteroid hormones: possible implications for therapy of neuroimmunological disorders. J Neuroimmunol 117:1\u20138","journal-title":"J Neuroimmunol"},{"key":"7007_CR12","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1212\/WNL.51.1.239","volume":"51","author":"Goodkin","year":"1998","unstructured":"Goodkin DE, Kinkel RP, Weinstock-Guttman B, VanderBrug-Medendorp S, Secic M, Gogol D, Perryman JE, Uccelli MM, Neilley L (1998) A phase II study of i.v. methylprednisolone in secondary-progressive multiple sclerosis. Neurology 51:239\u2013245","journal-title":"Neurology"},{"key":"7007_CR13","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1100\/tsw.2006.86","volume":"6","author":"Hellwig","year":"2006","unstructured":"Hellwig K, Lukas C, Brune N, Schimrigk S, Przuntek H, Muller T (2006) Repeat intrathecal triamcinolone acetonide application reduces acute occurring painful dysesthesia in patients with relapsing remitting multiple sclerosis. ScientificWorldJournal 6:460\u2013465","journal-title":"ScientificWorldJournal"},{"key":"7007_CR14","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1471-2377-4-18","volume":"4","author":"Hellwig","year":"2004","unstructured":"Hellwig K, Stein FJ, Przuntek H, Muller T (2004) Efficacy of repeated intrathecal triamcinolone acetonide application in progressive multiple sclerosis patients with spinal symptoms. BMC Neurol 4:18","journal-title":"BMC Neurol"},{"key":"7007_CR15","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0140-6736(05)67102-4","volume":"366","author":"Keegan","year":"2005","unstructured":"Keegan M, Konig F, McClelland R, Bruck W, Morales Y, Bitsch A, Panitch H, Lassmann H, Weinshenker B, Rodriguez M, Parisi J, Lucchinetti CF (2005) Relation between humoral pathological changes in multiple sclerosis and response to therapeutic plasma exchange. Lancet 366:579\u2013582","journal-title":"Lancet"},{"key":"7007_CR16","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1212\/WNL.35.3.312","volume":"35","author":"Khatri","year":"1985","unstructured":"Khatri BO, McQuillen MP, Harrington GJ, Schmoll D, Hoffmann RG (1985) Chronic progressive multiple sclerosis: double-blind controlled study of plasmapheresis in patients taking immunosuppressive drugs. Neurology 35:312\u2013319","journal-title":"Neurology"},{"key":"7007_CR17","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1001\/archneur.63.7.930","volume":"63","author":"Lehmann","year":"2006","unstructured":"Lehmann HC, Hartung HP, Hetzel GR, Stuve O, Kieseier BC (2006) Plasma exchange in neuroimmunological disorders: Part 1: Rationale and treatment of inflammatory central nervous system disorders. Arch Neurol 63:930\u2013935","journal-title":"Arch Neurol"},{"key":"7007_CR18","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1007\/s00415-006-0497-0","volume":"254","author":"Linker","year":"2007","unstructured":"Linker RA, Chan A, Sommer M, Koziolek M, Muller GA, Paulus W, Gold R (2007) Plasma exchange therapy for steroid-refractory superimposed relapses in secondary progressive multiple sclerosis. J Neurol 254:1288\u20131289","journal-title":"J Neurol"},{"key":"7007_CR19","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1136\/jnnp.50.5.511","volume":"50","author":"Milligan","year":"1987","unstructured":"Milligan NM, Newcombe R, Compston DA (1987) A double-blind controlled trial of high dose methylprednisolone in patients with multiple sclerosis: 1. Clinical effects. J Neurol Neurosurg Psychiatry 50:511\u2013516","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"7007_CR20","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1212\/01.WNL.0000138572.82125.F5","volume":"63","author":"Morrow","year":"2004","unstructured":"Morrow SA, Stoian CA, Dmitrovic J, Chan SC, Metz LM (2004) The bio-availability of IV methylprednisolone and oral prednisone in multiple sclerosis. Neurology 63:1079\u20131080","journal-title":"Neurology"},{"key":"7007_CR21","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1212\/WNL.50.6.1833","volume":"50","author":"Oliveri","year":"1998","unstructured":"Oliveri RL, Valentino P, Russo C, Sibilia G, Aguglia U, Bono F, Fera F, Gambardella A, Zappia M, Pardatscher K, Quattrone A (1998) Randomized trial comparing two different high doses of methylprednisolone in MS: a clinical and MRI study. Neurology 50:1833\u20131836","journal-title":"Neurology"},{"key":"7007_CR22","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1007\/s00115-006-2220-x","volume":"77","author":"Rieckmann","year":"2006","unstructured":"Rieckmann P (2006) Escalating immunomodulatory therapy of multiple sclerosis. Update (September 2006). Nervenarzt 77:1506\u20131518","journal-title":"Nervenarzt"},{"key":"7007_CR23","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1212\/01.WNL.0000138437.99046.6B","volume":"63","author":"Ruprecht","year":"2004","unstructured":"Ruprecht K, Klinker E, Dintelmann T, Rieckmann P, Gold R (2004) Plasma exchange for severe optic neuritis: treatment of 10 patients. Neurology 63:1081\u20131083","journal-title":"Neurology"},{"key":"7007_CR24","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1007\/s00115-005-2019-1","volume":"77","author":"Schilling","year":"2006","unstructured":"Schilling S, Linker RA, Konig FB, Koziolek M, Bahr M, Muller GA, Paulus W, Gartner J, Bruck W, Chan A, Gold R (2006) Plasma exchange therapy for steroid-unresponsive multiple sclerosis relapses: clinical experience with 16 patients. Nervenarzt 77:430\u2013438","journal-title":"Nervenarzt"},{"key":"7007_CR25","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1212\/WNL.39.7.969","volume":"39","author":"Thompson","year":"1989","unstructured":"Thompson AJ, Kennard C, Swash M, Summers B, Yuill GM, Shepherd DI, Roche S, Perkin GD, Loizou LA, Ferner R, et al. (1989) Relative efficacy of intravenous methylprednisolone and ACTH in the treatment of acute relapse in MS. Neurology 39:969\u2013971","journal-title":"Neurology"},{"key":"7007_CR26","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jneuroim.2006.11.031","volume":"183","author":"Tischner","year":"2007","unstructured":"Tischner D, Weishaupt A, van den Brandt J, Ip CW, Kerkau T, Gold R, Reichardt HM (2007) Antigen therapy of experimental autoimmune encephalomyelitis selectively induces apoptosis of pathogenic T cells. J Neuroimmunol 183:146\u2013150","journal-title":"J Neuroimmunol"},{"key":"7007_CR27","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1001\/archneur.1965.00460290092010","volume":"12","author":"Tourtellotte","year":"1965","unstructured":"Tourtellotte WW, Haerer AF (1965) Use of an Oral Corticosteroid in the Treatment of Multiple Sclerosis; a Double-Blind Study. Arch Neurol 12:536\u2013545","journal-title":"Arch Neurol"},{"key":"7007_CR28","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1212\/WNL.39.9.1143","volume":"39","author":"Weiner","year":"1989","unstructured":"Weiner HL, Dau PC, Khatri BO, Petajan JH, Birnbaum G, McQuillen MP, Fosburg MT, Feldstein M, Orav EJ (1989) Double-blind study of true vs. sham plasma exchange in patients treated with immunosuppression for acute attacks of multiple sclerosis. Neurology 39:1143\u20131149","journal-title":"Neurology"},{"key":"7007_CR29","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/(SICI)1098-1101(1999)14:3<144::AID-JCA7>3.0.CO;2-R","volume":"14","author":"Weinshenker","year":"1999","unstructured":"Weinshenker BG (1999) Therapeutic plasma exchange for acute inflammatory demyelinating syndromes of the central nervous system. J Clin Apher 14:144\u2013148","journal-title":"J Clin Apher"},{"key":"7007_CR30","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1212\/WNL.57.7.1239","volume":"57","author":"Zivadinov","year":"2001","unstructured":"Zivadinov R, Rudick RA, De Masi R, Nasuelli D, Ukmar M, Pozzi-Mucelli RS, Grop A, Cazzato G, Zorzon M (2001) Effects of IV methylprednisolone on brain atrophy in relapsingremitting MS. Neurology 57:1239\u20131247","journal-title":"Neurology"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-008-6007-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-008-6007-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-008-6007-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T15:08:19Z","timestamp":1559056099000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-008-6007-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":30,"journal-issue":{"issue":"S6","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["7007"],"URL":"https:\/\/doi.org\/10.1007\/s00415-008-6007-9","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,12]]}}}